Bipolar disorder treatment: An evidence-based reality check

American Journal of Psychiatry

Volumn 163, Issue 2, 2006, Pages 175-176

  DePaulo Jr , J Raymond ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; DEPRESSION; DISEASE COURSE; EDITORIAL; EVIDENCE BASED MEDICINE; MANIA; ONSET AGE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; GENETIC HETEROGENEITY; GENETICS; HUMAN; MULTIMODALITY CANCER THERAPY; NOTE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ANTIDEPRESSANT AGENT;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; GENETIC HETEROGENEITY; HUMANS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TREATMENT OUTCOME;

EID: 33645011832     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.2.175     Document Type: Editorial

References (9)

1. Prien RF, Caffey EM Jr, Klett CJ: A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives; report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972; 27:182-189
2. Prien RF, Caffey EM Jr, Klett CJ: Prophylactic efficacy of lithium carbonate in manic-depressive illness: report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1973; 28:337-341
3. McCreadie RG, Morrison DP: The impact of lithium in south-west Scotland, I: demographic and clinical findings. Br J Psychiatry 1985; 146:70-74
4. Morrison DP, McCreadie RG: The impact of lithium in south-west Scotland, II: a longitudinal study. Br J Psychiatry 1985; 146:74-77
5. McCreadie RG, McCormick M, Morrison DP: The impact of lithium in South-West Scotland, III: the discontinuation of lithium. Br J Psychiatry 1985; 146:77-80
6. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (Clinical Antipsychotic Trials of Intervention Effectiveness [CATIE] Investigators): Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223
7. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (STAR*D Study Team): Outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163:28-40
8. McMahon FJ, Stine OC, Chase GA, Meyers DA, Simpson SG, DePaulo JR Jr: Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry 1994; 151:210-215
9. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM: The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31:281-294